SCHEMBL30340342

SCHEMBL30340342

COc1cc(C(F)=Cc2cccc(-c3ccccc3C)c2C)ccc1CO

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDCD1 Q15116 15/20 0.50
▸ CD274 Q9NZQ7 15/20 0.50
▸ S1PR1 P21453 2/20 0.38
▸ MEN1 O00255 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ TUBB4A P04350 1/20 0.33
▸ TUBB P07437 1/20 0.33
▸ TUBA3C P0DPH7 1/20 0.33
▸ TUBA1B P68363 1/20 0.33
▸ TUBA4A P68366 1/20 0.33
▸ TUBB4B P68371 1/20 0.33
▸ TUBB3 Q13509 1/20 0.33
▸ TUBB2A Q13885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30340553 0.84 PDCD1 (0.45) PDCD1CD274MEN1CYP1A2CYP2D6
SCHEMBL21623441 0.84 PDCD1 (0.45) PDCD1CD274MEN1CYP1A2CYP2D6
SCHEMBL30340633 0.83 ALDH1A1 (0.38) PDCD1CD274S1PR1CYP1A2TSHR
SCHEMBL21622945 0.81 CD274 (0.53) PDCD1CD274
SCHEMBL30340399 0.81 CD274 (0.48) PDCD1CD274
SCHEMBL21623099 0.80 CD274 (0.42) PDCD1CD274
SCHEMBL21622942 0.79 CD274 (0.48) PDCD1CD274
SCHEMBL30340423 0.79 CD274 (0.48) PDCD1CD274
SCHEMBL21622950 0.79 CD274 (0.39) PDCD1CD274
SCHEMBL28472791 0.79 CD274 (0.43) PDCD1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111886219-B Immunosuppressant, preparation method and pharmaceutical application thereof 上海和誉生物医药科技有限公司 2023-04-25 — — CN disclosed
Send feedback